The trajectory of Sildenafil presents a interesting case for investors in the pharmaceutical sector. While initially a phenomenal success, producing billions, the patent end and the subsequent flood of generic https://knockoff867560.alltdesign.com/the-little-copyright-and-big-pharma-a-risky-bet-60499924